Theriva Biologics
TOVX
TOVX
20 hedge funds and large institutions have $177K invested in Theriva Biologics in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.34% more ownership
Funds ownership: 3.21% → 4.55% (+1.3%)
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$25.1K | |
| 2 | +$14.9K | |
| 3 | +$11.1K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$9.28K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.63K |
Top Sellers
| 1 | -$15.6K | |
| 2 | -$7.73K | |
| 3 | -$1.3K | |
| 4 |
BlackRock
New York
|
-$25 |
| 5 |
PW
Pandora Wealth
Oakbrook Terrace,
Illinois
|
-$2 |
